IDEXX Laboratories Inc (IX1.BE)

416.90

+4.90

+(1.19%)

As of 8:08:18 AM GMT+2. Market Open.

Idexx Laboratories price target raised to $460 from $420 at Stifel

Stifel raised the firm’s price target on Idexx Laboratories (IDXX) to $460 from $420 and keeps a Hold rating on the shares. The firm says that the company’s Q1 results were not surprising, but the stock’s reaction was a bit stronger than expected. Stifel will continue to monitor the uptake of Cancer Dx and inVue, but for now the firm believes the near-term contribution is already reflected in estimates. Published first on TheFly – the ultimate source for real-time, market-moving breaking financi

TipRanks 3 days ago

IDXX
IDEXX Laboratories [NasdaqGS:IDXX] Raises 2025 Guidance and Reports Q1 Growth in Revenue and EPS

IDEXX Laboratories (NasdaqGS:IDXX) experienced a 13% price increase over the last month, spurred by robust first-quarter earnings results and an optimistic upward revision in corporate guidance. The company reported an increase in sales and net income compared to the previous year, projecting confidence for the remainder of 2025. These positive events coincided with a broader market uptick, including a strong U.S. jobs report and potential trade talk optimism, both bolstering the S&P 500's...

Simply Wall St. 3 days ago

IDXX
IDEXX Laboratories Inc (IDXX) Q1 2025 Earnings Call Highlights: Strong Organic Growth Amid ...

IDEXX Laboratories Inc (IDXX) reports robust revenue growth driven by diagnostics and consumables, despite facing headwinds in clinical visits and foreign exchange impacts.

GuruFocus.com 4 days ago

IDXX
IDXX Q1 Earnings Beat, FY25 View Raised, Stock Up in Pre-Market

IDEXX delivers year-over-year earnings and revenue growth in the first quarter of 2025.

Zacks 5 days ago

IDXX
Compared to Estimates, Idexx (IDXX) Q1 Earnings: A Look at Key Metrics

Although the revenue and EPS for Idexx (IDXX) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks 5 days ago

IDXX
Does IDEXX Laboratories (NASDAQ:IDXX) Deserve A Spot On Your Watchlist?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Simply Wall St. 5 days ago

IDXX
Idexx Laboratories (IDXX) Beats Q1 Earnings Estimates

Idexx (IDXX) delivered earnings and revenue surprises of 1.37% and 1.77%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 5 days ago

IDXX
Idexx: Q1 Earnings Snapshot

WESTBROOK, Maine (AP) — Idexx Laboratories Inc. IDXX) on Thursday reported first-quarter profit of $242.7 million. On a per-share basis, the Westbrook, Maine-based company said it had profit of $2.96.

Associated Press Finance 5 days ago

IDXX
IDEXX Laboratories Announces First Quarter Results

WESTBROOK, Maine, May 01, 2025--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced first quarter results.

Business Wire 5 days ago

IDXX
Watch These 3 MedTech Stocks This Earnings Season: Beat or Miss?

MedTech bigwigs, such as CVS, HOLX and IDXX, are set to post their quarterly results tomorrow. Can they deliver on expectations?

Zacks 6 days ago

HOLX

IDXX

CVS
Waters (WAT) Reports Next Week: Wall Street Expects Earnings Growth

Waters (WAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 7 days ago

IDXX
Why Idexx Laboratories (IDXX) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks 7 days ago

IDXX
Seeking Clues to Idexx (IDXX) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics

Besides Wall Street's top -and-bottom-line estimates for Idexx (IDXX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.

Zacks 7 days ago

IDXX
Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth

Idexx (IDXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 12 days ago

IDXX
Idexx Laboratories price target lowered to $475 from $535 at BofA

BofA lowered the firm’s price target on Idexx Laboratories (IDXX) to $475 from $535 and keeps a Neutral rating on the shares. Heading into Q1 earnings, the firm says sentiment on its animal health coverage “skews generally negative,” with a number of broader market and company-specific headwinds. The firm sees limited near-term catalysts to drive estimates higher beyond improved foreign exchange rates, so it thinks shares will remain capped near current levels, the analyst added in a preview for

TipRanks 13 days ago

IDXX
IDXX Gears Up for Q1 Earnings: What to Expect From the Stock?

IDEXX Laboratories' first-quarter 2025 performance is expected to have benefited from a strong execution against strategic priorities.

Zacks 15 days ago

IDXX
IDEXX (IDXX) Surges 10.0%: Is This an Indication of Further Gains?

IDEXX (IDXX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Zacks 26 days ago

IDXX
IDEXX Laboratories (NasdaqGS:IDXX) Price Moves -14% Over The Last Week Amid Market Volatility

IDEXX Laboratories (NasdaqGS:IDXX) experienced a 14% decline over the last week, in line with the broader market turmoil where the S&P 500 fell by 12% amid heightened tariff tensions between the U.S. and China. The recent market volatility, driven by the imposition of new tariffs and China’s retaliatory measures, has largely weighed on various sectors, including healthcare and technology, which impact IDEXX's operational landscape. While some sectors like technology managed gains due to...

Simply Wall St. 26 days ago

IDXX
Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks 27 days ago

IDXX
Should You Sell IDEXX Laboratories (IDXX)?

TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the fourth quarter, the strategy returned -1.35% (gross) and -1.56% (net) compared to 8.14% for the Russell Midcap Growth Index. In the fourth quarter, the U.S. small […]

Insider Monkey 29 days ago

IDXX

Performance Overview

Return	IX1.BE	S&P 500 (^GSPC)
YTD	+5.62%	-4.39%
1-Year	-6.34%	+8.55%
3-Year	+15.18%	+36.38%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Live

IDEXX Laboratories Inc (IX1.BE)

Idexx Laboratories price target raised to $460 from $420 at Stifel

IDEXX Laboratories [NasdaqGS:IDXX] Raises 2025 Guidance and Reports Q1 Growth in Revenue and EPS

IDEXX Laboratories Inc (IDXX) Q1 2025 Earnings Call Highlights: Strong Organic Growth Amid ...

IDXX Q1 Earnings Beat, FY25 View Raised, Stock Up in Pre-Market

Compared to Estimates, Idexx (IDXX) Q1 Earnings: A Look at Key Metrics

Does IDEXX Laboratories (NASDAQ:IDXX) Deserve A Spot On Your Watchlist?

Idexx Laboratories (IDXX) Beats Q1 Earnings Estimates

Idexx: Q1 Earnings Snapshot

IDEXX Laboratories Announces First Quarter Results

Watch These 3 MedTech Stocks This Earnings Season: Beat or Miss?

Waters (WAT) Reports Next Week: Wall Street Expects Earnings Growth

Why Idexx Laboratories (IDXX) is a Top Growth Stock for the Long-Term

Seeking Clues to Idexx (IDXX) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics

Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth

Idexx Laboratories price target lowered to $475 from $535 at BofA

IDXX Gears Up for Q1 Earnings: What to Expect From the Stock?

IDEXX (IDXX) Surges 10.0%: Is This an Indication of Further Gains?

IDEXX Laboratories (NasdaqGS:IDXX) Price Moves -14% Over The Last Week Amid Market Volatility

Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock

Should You Sell IDEXX Laboratories (IDXX)?

Performance Overview